Rocket Lab USA, Inc. Work in process increased by 10.7% to $76.06M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 43.9%, from $52.86M to $76.06M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 41.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.36M | $24.17M | $48.83M | $50.35M | $48.20M | $50.66M | $50.76M | $46.53M | $43.99M | $53.63M | $48.82M | $52.28M | $65.19M | $60.46M | $52.86M | $54.96M | $69.99M | $68.71M | $76.06M |
| QoQ Change | — | +18.7% | +102.0% | +3.1% | -4.3% | +5.1% | +0.2% | -8.3% | -5.5% | +21.9% | -9.0% | +7.1% | +24.7% | -7.3% | -12.6% | +4.0% | +27.3% | -1.8% | +10.7% |
| YoY Change | — | — | — | — | +136.7% | +109.6% | +4.0% | -7.6% | -8.7% | +5.9% | -3.8% | +12.4% | +48.2% | +12.7% | +8.3% | +5.1% | +7.4% | +13.6% | +43.9% |
| % of Inventories | 53.1% | 50.4% | 62.7% | 58.8% | 56.0% | 54.9% | 51.6% | 45.5% | 43.0% | 49.7% | 48.9% | 50.0% | 57.0% | 50.8% | 42.1% | 42.2% | 48.3% | 43.4% | 41.5% |
| Share Change | — | -2.6pp | +12.2pp | -3.9pp | -2.8pp | -1.1pp | -3.3pp | -6.0pp | -2.5pp | +6.8pp | -0.9pp | +1.1pp | +7.0pp | -6.2pp | -8.7pp | +0.1pp | +6.1pp | -4.9pp | -1.8pp |